The regulator said it withdrew authorisation for the drug on Sept. 25. It added that the authorisation holder, listed as ...

Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to ...

Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter to AbbVie, Inc., regarding a television ad starring Serena Williams for its migraine medicine Ubrelvy. According to the ...

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

With Tremfya also securing approval in UC earlier this month, competition promises to be fierce among the IL-23s, according to .EXTON, PA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The past twelve months have ...

A roundup of current health news includes Johnson & Johnson's $2 billion investment in a new manufacturing facility, CVS ...

Leerink Partners analyst David Risinger has maintained their neutral stance on BMY stock, giving a Hold rating on September 26. David Risinger ...

The global hyaluronic acid products market is on a strong growth trajectory, with an anticipated valuation of USD 3,343.5 ...

The insurers are looking to disrupt Big Pharma's model of distributing drugs. One of them's even offering to give them to ...

AbbVie (ABBV) stock price has done well this year as it surged to a record high of $200. It has jumped by more than 32% this ...

UCB taps new UK head. Belgium-based global biopharmaceutical company UCB welcomed Nico Reynders as its new general manager ...

Headlines,Mosaic Brands to Streamline by Closing Five Non-Core Brands and 200+ Stores,Focus Shifts to Core Brands and Digital ...